Report overview
A prescription drug is a pharmaceutical drug that legally requires a medical prescription to be dispensed.
This report contains market size and forecasts of Prescription Respiratory Drugs in global, including the following market information:
Global Prescription Respiratory Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Prescription Respiratory Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Prescription Respiratory Drugs companies in 2021 (%)
The global Prescription Respiratory Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-Inflammatories Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prescription Respiratory Drugs include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prescription Respiratory Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prescription Respiratory Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prescription Respiratory Drugs Market Segment Percentages, by Type, 2021 (%)
Anti-Inflammatories
Mast Stabilizers
Antihistamines
Bronchodilators
Other Respiratory Drugs
Global Prescription Respiratory Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prescription Respiratory Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce
Global Prescription Respiratory Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prescription Respiratory Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prescription Respiratory Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Prescription Respiratory Drugs revenues share in global market, 2021 (%)
Key companies Prescription Respiratory Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Prescription Respiratory Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Boehringer Ingelheim
GlaxoSmithKline
Merck
